Pre-Drawn Syringes of Comirnaty for an Efficient COVID-19 Mass Vaccination: Demonstration of Stability
Moving towards a real mass vaccination in the context of COVID-19, healthcare professionals are required to face some criticisms due to limited data on the stability of a mRNA-based vaccine (Pfizer-BioNTech COVID-19 Vaccine in the US or Comirnaty in EU) as a dose in a 1 mL-syringe. The stability of...
Saved in:
Main Authors: | Francesca Selmin (Author), Umberto M. Musazzi (Author), Silvia Franzè (Author), Edoardo Scarpa (Author), Loris Rizzello (Author), Patrizia Procacci (Author), Paola Minghetti (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process
by: Antonella Casiraghi, et al.
Published: (2020) -
Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
by: Silvia Franzé, et al.
Published: (2018) -
Considerations on D-mannose Mechanism of Action and Consequent Classification of Marketed Healthcare Products
by: Francesco Scaglione, et al.
Published: (2021) -
Drawn to Story
by: Daniel Gregson
Published: (2020) -
Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccine
by: Aaron J. Frederiks, MD, et al.
Published: (2022)